Tenpoint Therapeutics Limited is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye. Its pipeline includes paradigm-shifting treatments for ophthalmic indications with the greatest need and global market potential, including presbyopia, cataracts and geographic atrophy. Its lead asset, BRIMOCHOL PF, is a novel, pupil-modulating therapeutic designed to correct the loss of near vision associated with presbyopia, a condition that afflicts approximately 2 billion people globally. BRIMOCHOL PF has completed its first Phase 3 pivotal trial (BRIO-I) and will complete the second pivotal study, BRIO-II, in 2025. This topical ophthalmic is poised for launch in 2026. Tenpoint’s leadership team includes ophthalmic industry luminaries with track records of successful approvals and commercialization of blockbuster drugs. A privately held company, Tenpoint Therapeutics is backed by AdBio Partners, British Patient Capital, Eight Roads, EQT Life Sciences, F-Prime Capital, Hillhouse Capital Management, Qiming Venture Partners USA, Sofinnova Partners, and UCL Technology Fund.
Company Details
- Employees
- 63
- Founded
- 2019
- Address
- London Innovation Centre, 20 Water Street,4th Floor Office 3
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Presbyopia, Ophthalmology, Optometry, Eye Health, Glaucoma, macular degeneration, dry eye disease, AMD, ocular surface disease, regenerative medicine.
- HQ
- London
Tenpoint Therapeutics, Ltd. Questions
Tenpoint Therapeutics, Ltd.'s website is http://www.tenpointtherapeutics.com
Tenpoint Therapeutics, Ltd.'s LinkedIn profile is https://www.linkedin.com/company/tenpointtherapeutics
Tenpoint Therapeutics, Ltd. has
63 employees.
View email and phone details for 63
employees at Tenpoint Therapeutics, Ltd..
Tenpoint Therapeutics, Ltd.'s industry is
Biotechnology Research
Tenpoint Therapeutics, Ltd.'s top competitors are
Bausch + Lomb,
Tarsus Pharmaceuticals, Inc.,
Eyenovia, Inc.,
Apellis Pharmaceuticals,
Ocular Therapeutix, Inc.,
Eyepoint,
Glaukos Corporation,
Lenz Therapeutics,
Tenpoint Therapeutics Ltd,
Orasis Pharmaceuticals.
Tenpoint Therapeutics, Ltd.'s categories are Biotechnology Research
Tenpoint Therapeutics, Ltd.'s founding year is 2019
